Concepedia

Maria Chiara Abbenante

MC

Statistics

Publications

14

Citations

520

H-Index

12

Active since

2010

Affiliations

University of Bologna(Current)

University of Brescia

Fondazione Gimema Onlus

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Istituti di Ricovero e Cura a Carattere Scientifico

Maria Chiara Abbenante is an author at University of Bologna specializing in medicine, acute lymphoblastic leukemia treatment, and oncology.

Publications per year

2010–2022

14

Publications

14

INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia

Giovanni Martinelli, Cristina Papayannidis, Alfonso Piciocchi et al. · Blood Advances · 2021 · 75 citations · Full text

, , +13

<i>CDKN2A/B</i> Alterations Impair Prognosis in Adult <i>BCR-ABL1</i> –Positive Acute Lymphoblastic Leukemia Patients

Ilaria Iacobucci, Anna Ferrari, Annalisa Lonetti et al. · Clinical Cancer Research · 2011 · 74 citations · Full text

, , +9

First Report of the Gimema LAL1811 Phase II Prospective Study of the Combination of Steroids with Ponatinib As Frontline Therapy of Elderly or Unfit Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Giovanni Martinelli, Alfonso Piciocchi, Cristina Papayannidis et al. · Blood · 2017 · 71 citations

, , +13

Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia

Andrea Ghelli Luserna di Rorà, Neil Beeharry, Enrica Imbrogno et al. · Journal of Hematology & Oncology · 2018 · 56 citations · Full text

, , +16

Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia

Andrea Ghelli Luserna di Rorà, Ilaria Iacobucci, Enrica Imbrogno et al. · Oncotarget · 2016 · 42 citations · Full text

, , +15

1–5 of 14